Day in Review: July 27, 2020

A daily recap of major events and headlines affecting the market with individual investors in mind.

  • Senate GOP unveils coronavirus relief plan with 70% wage replacement in unemployment insurance
  • Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday. U.S. drugmaker Pfizer and German biotech BioNTech said they began their late-stage human trial for a potential coronavirus vaccine on Monday as pharmaceutical companies race to win regulatory approval before the end of the year.
  • Top CEOs ramp up GOP donations as Biden threatens to scale back corporate tax cuts. Of the top 10 political donors among S&P 500 CEOs, a majority gave big to GOP groups in the second quarter, according to data from the Center for Responsive Politics.
  • Hasbro revenue falls 29% as store closures, product shortages hurt sales; shares drop. Store closures, product shortages and lower retail inventory hampered Hasbro in the second quarter, as the company posted weaker-than-expected earnings on Monday.


The Future of Stock News

We are launching a news platform that filters out the noise and shows only the most relevant and important news to you.